The missense mutation EGFR L858R in exon 21, which accounts for 41% of all EGFR mutations, has been detected in lung cancer, colorectal cancer, and squamous cell carcinoma of the head and neck (Shigematsu and Gazdar, 2006). This evidence concerns the gene EGFR and squamous cell carcinoma.